Was watson even expecting this approval? I just did a quick word search in WPI 2010 annual report and no mention of lovenox or amphastar...and I have not heard them mention the program on CC, etc
Any comments here may have previously been disseminated on Twitter @BioDueDiligence or at www.biotechduediligence.com